Sort
141,003 grants matching “cytokine”
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,958,258Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Cell Migration in 3D microenvironments
$2,956,754Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,953,179Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2023 · CA
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$2,943,796Alan Sher · Niaid Extramural Activities · Z01 · FY2007 · AI
Systemic Autoimmunity
$2,931,661Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2020 · AR
Systemic Autoimmunity
$2,923,882Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,922,916Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2024 · CA
Single Cell Resolution Omics Analysis of T1D islets
$2,914,519Charles K Ansong · Battelle Pacific Northwest Laboratories · UC4 · FY2015 · DK
PACT
$2,914,187Leslie Eric Silberstein · Immune Disease Institute, Inc. · N01 · FY2012 · HL
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$2,911,139John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
MECHANISMS AND TREATMENT OF COPD PROGRESSION
$2,908,696Robert A. Wise · Johns Hopkins University · P50 · FY2008 · HL
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
$2,906,437Leah Helane Rubin · Johns Hopkins University · RF1 · FY2023 · MH
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
$2,905,942Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2025 · CA
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,904,866Rachel R. Caspi · National Eye Institute · Z01 · FY2008 · EY
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,904,544Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Targeting Cellular Senescence to Extend Healthspan
$2,897,046Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2019 · AG
Multiple Ascending Dose clinical trial of PTI-125, a novel AD therapeutic candidate
$2,896,561Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2019 · AG
Solid oral dosage form and chronic tox for PTI-125
$2,896,320Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2018 · AG
Genetic Approaches To Understanding Organ Development and Function
$2,894,006Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Dietary fat-activated colonocyte-macrophage ketone shuttle drives intestinal inflammation
$2,893,480Hai-Bin Ruan · University Of Minnesota · R01 · FY2025 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$2,892,333Pamela Schwartzberg · Human Genome Research · Z01 · FY2007 · HG
Genetic analysis of type II diabetes in Finnish population
$2,889,053Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2021 · HG
Activities Of Chemokines In Vivo
$2,888,396Joshua M Farber · Niaid Extramural Activities · Z01 · FY2007 · AI
Understanding Asthma Endotypes
$2,888,226David J Erle · University Of California, San Francisco · U19 · FY2021 · AI
Single cell RNA-seq analyses of age-related changes in glial cells and in AD
$2,885,990Junying Yuan · Harvard Medical School · RF1 · FY2017 · AG